Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients

Condition:   Breast Cancer Intervention:   Drug: metronomic oral vinorelbine plus anlotinib Sponsor:   Yan Xue Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials